Spirit Scientific Biotech is participating in the BIO Asia-Taiwan exhibition for the first time.
The well-known media outlet conducted a interview video with us.
Steven D. Lin, co-founder and chairman of Spirit Scientific Biotech, made his first appearance at BIO Asia-Taiwan, sharing the company’s innovative plans in the field of regenerative medicine.
Spirit Scientific Biotech focuses on the pharmaceutical and standardization of biomaterials.
Their core technology, BMLT, can significantly improve the stability and shelf life of biomaterials.
Their first product, Platelet Lyphoilized Treatment (PLT), is currently the safest and most complete pharmaceutical solution for platelet therapy, transforming platelet therapy into quantifiable and precise medicine.
Steven D. Lin stated that Spirit Scientific Biotech hopes to establish collaborations with domestic and international experts and medical centers to jointly promote the development of precision medicine and regenerative medicine.
Source: https://news.gbimonthly.com/tw/celebrity/show.php?num=79941
